z-logo
open-access-imgOpen Access
GSK 650394 Inhibits Osteoclasts Differentiation and Prevents Bone Loss via Promoting the Activities of Antioxidant Enzymes In Vitro and In Vivo
Author(s) -
LinYu Jin,
Shicheng Huo,
Chen Guo,
Hai-Ying Liu,
Shuai Xu,
XinFeng Li
Publication year - 2022
Publication title -
oxidative medicine and cellular longevity
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.494
H-Index - 93
eISSN - 1942-0900
pISSN - 1942-0994
DOI - 10.1155/2022/3458560
Subject(s) - rankl , osteoclast , osteoblast , chemistry , in vivo , bone resorption , osteolysis , microbiology and biotechnology , downregulation and upregulation , activator (genetics) , mapk/erk pathway , signal transduction , osteoporosis , intracellular , in vitro , cancer research , endocrinology , biochemistry , receptor , biology , medicine , gene , surgery

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom